Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function

被引:104
作者
Riemersma, S
Vincent, A
Beeson, D
Newland, C
Hawke, S
Garabedian, BV
Eymard, B
NewsomDavis, J
机构
[1] UNIV OXFORD, JOHN RADCLIFFE HOSP,INST MOL MED,DEPT CLIN NEUROL, NEUROSCI GRP, OXFORD OX3 9DU, ENGLAND
[2] HOP NECKER ENFANTS MALAD, INSERM U25, PARIS, FRANCE
关键词
myasthenia gravis; arthrogryposis; acetylcholine receptor; placental-to-fetal transfer; autoantibody;
D O I
10.1172/JCI119048
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Arthrogryposis multiplex congenita (AMC), characterized by multiple joint contractures developing in utero, results from lack of fetal movement, Some cases are genetically determined, but AMC occasionally complicates pregnancy in patients with myasthenia gravis (MG) suggesting involvement of circulating maternal antibodies, We previously demonstrated antibodies that inhibited the function of fetal acetylcholine receptor (AChR) in one healthy woman with an obstetric history of recurrent AMC, Here we study sera from this woman, from one other with a similar history, and from three (one asymptomatic) whose babies had neonatal MG and AMC, All five maternal sera had high titers of antibodies that inhibited alpha-Bungarotoxin (alpha-BuTx) binding to fetal AChR, and their sera markedly inhibited fetal AChR function with little effect on adult AChR function. Moreover, in a further survey, 3 of 20 sera from anti-AChR negative AMC mothers inhibited fetal AChR function significantly at 1:100 dilution, These results demonstrate the role of antibodies to fetal AChR and perhaps other muscle antigens in some cases of AMC, More generally, they suggest that placental transfer of antibodies directed at fetal antigens should be considered as a cause of other recurrent fetal or perinatal disorders.
引用
收藏
页码:2358 / 2363
页数:6
相关论文
共 31 条
[1]   RECURRENT CONGENITAL ARTHROGRYPOSIS LEADING TO A DIAGNOSIS OF MYASTHENIA-GRAVIS IN AN INITIALLY ASYMPTOMATIC MOTHER [J].
BARNES, PRJ ;
KANABAR, DJ ;
BRUETON, L ;
NEWSOMDAVIS, J ;
HUSON, SM ;
MANN, NP ;
HILTONJONES, D .
NEUROMUSCULAR DISORDERS, 1995, 5 (01) :59-65
[2]   PLASMA FROM PATIENTS WITH SERONEGATIVE MYASTHENIA-GRAVIS INHIBIT NACHR RESPONSES IN THE TE671/RD CELL-LINE [J].
BARRETTJOLLEY, R ;
BYRNE, N ;
VINCENT, A ;
NEWSOMDAVIS, J .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1994, 428 (5-6) :492-498
[3]   Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit [J].
Beeson, D ;
Amar, M ;
Bermudez, I ;
Vincent, A ;
NewsomDavis, J .
NEUROSCIENCE LETTERS, 1996, 207 (01) :57-60
[4]   A MYASTHENIA-GRAVIS PLASMA IMMUNOGLOBULIN REDUCES MINIATURE ENDPLATE POTENTIALS AT HUMAN ENDPLATES INVITRO [J].
BURGES, J ;
WRAY, DW ;
PIZZIGHELLA, S ;
HALL, Z ;
VINCENT, A .
MUSCLE & NERVE, 1990, 13 (05) :407-413
[5]  
CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63
[6]   ARTHROGRYPOSIS MULTIPLEX IN A NEWBORN OF A MYASTHENIC MOTHER - CASE-REPORT AND LITERATURE [J].
DINGER, J ;
PRAGER, B .
NEUROMUSCULAR DISORDERS, 1993, 3 (04) :335-339
[7]   MONOCLONAL-ANTIBODIES SPECIFIC FOR EACH OF THE 2 TOXIN-BINDING SITES OF TORPEDO ACETYLCHOLINE-RECEPTOR [J].
DOWDING, AJ ;
HALL, ZW .
BIOCHEMISTRY, 1987, 26 (20) :6372-6381
[8]   MEDICAL PROGRESS - MYASTHENIA-GRAVIS [J].
DRACHMAN, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (25) :1797-1810
[9]   ROLE OF MOVEMENT IN EMBRYONIC JOINT DEVELOPMENT [J].
DRACHMAN, DB ;
SOKOLOFF, L .
DEVELOPMENTAL BIOLOGY, 1966, 14 (03) :401-+
[10]  
GUZMANENRIQUEZ L, 1990, J RHEUMATOL, V17, P52